News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
Research News & Stories
Clinical, In the Media, Research
Tumor Markers May Help Doctors Decide Which Head and Neck Cancer Patients Need Immunotherapy Before Surgery
WashU Medicine physician-scientists at Siteman Cancer Center identify a promising way to help guide immunotherapy treatment decisions and enhance patient care Building upon more than a decade of investigator-initiated clinical trials at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, researchers have identified a malignant cell biomarker that may predict which patients will respond to the […]
Clinical, In the Media, Research
Innovative CAR-T cell therapy receives FDA breakthrough therapy designation
Immunotherapy for aggressive T-cell cancers developed by WashU Medicine researchers moves to faster approval pathway A cell-based immunotherapy designed to treat rare and aggressive types of blood cancer has been granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA). Developed by researchers at Washington University School of Medicine in St. Louis, this […]
In the Media, Research, Staff/Faculty Update
Grant furthers novel therapeutic approach to glioblastoma
Mosquito-borne Zika virus helps destroy deadly brain cancer in mice Milan G. Chheda, MD, an associate professor of medicine in the Division of Oncology at WashU Medicine and a brain tumor specialist at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, has received a nearly $1.5 million grant from the Robert J. Kleberg, […]
Clinical, In the Media, Research
FDA Breakthrough Therapy Designation Reflects Practice-Changing Trends Only at Siteman
Recognition follows strong early clinical results for a novel off-the-shelf CAR T therapy targeting rare and aggressive T-cell malignancies A novel off-the-shelf CAR T-cell therapy pioneered at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine is gaining national recognition after delivering striking clinical results in patients with rare and aggressive blood cancers. The FDA […]
In the Media, Research
Siteman Cancer Center announces 2026 American Cancer Society-funded pilot projects
WashU Medicine grant recipients will focus on lung and blood cancers Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, is pleased to announce the next cohort of pilot projects funded by the Institutional Research Grant from the American Cancer Society. The three projects are described below. Under the leadership of Jason Weber, PhD, […]
In the Media, Research
New imaging approach reduces unnecessary breast biopsies by nearly 25%
WashU researchers at Siteman Cancer Center are advancing breast imaging to help patients avoid invasive procedures and improve the screening experience In a new discovery at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, a team of researchers and physicians found that utilizing ultrasound-guided diffuse optical tomography technology can reduce unnecessary breast biopsy rates by nearly […]
In the Media, Patient Resource, Research
Siteman Kids is the first site of multicenter CAR-T trial for autoimmune diseases
Access to the novel immunotherapy — which “has the potential for cure” — is the latest offering by the national leader in pediatric hematology, oncology, and cell therapies. Siteman Kids at St. Louis Children’s Hospital, along with WashU Medicine, is the first site to test a novel immunotherapy drug for the treatment of autoimmune diseases […]
In the Media, Research
Inflammatory immune cells predict survival, relapse in multiple myeloma
New ‘atlas’ of immune cells in bone marrow cancer lays foundation for more reliable prognosis A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma cells of the bone marrow and has no cure. This large immune cell atlas, which includes […]
In the Media, Research
Ratner receives $9.86 million grant to study cancers caused by retrovirus
Lee Ratner, MD, PhD, the Alan A. and Edith L. Wolff Professor of Oncology at WashU Medicine, has been awarded a five-year, $9.86 million grant from the National Institutes of Health (NIH) to investigate cancers caused by human retroviruses. This NIH Research Program Project Grant, which includes collaborators at The Ohio State University, supports a […]
Research
Nasal drops fight brain tumors noninvasively
Nano-sized medicine boosts anti-cancer immune response, eradicates tumors in mice Researchers at Washington University School of Medicine in St. Louis, along with collaborators at Northwestern University, have developed a noninvasive approach to treat one of the most aggressive and deadly brain cancers. Their technology uses precisely engineered structures assembled from nano-size materials to deliver potent […]